Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015

BACKGROUND: Artemisinin-based combination therapy is the first-line anti-malarial treatment for uncomplicated Plasmodium falciparum infection in Angola. To date, the prevalence of polymorphisms in the pfk13 gene, associated with artemisinin resistance, and pfmdr1, associated with lumefantrine resist...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Malar J
Päätekijät: Ljolje, Dragan, Dimbu, Pedro Rafael, Kelley, Julia, Goldman, Ira, Nace, Douglas, Macaia, Aleixo, Halsey, Eric S., Ringwald, Pascal, Fortes, Filomeno, Udhayakumar, Venkatachalam, Talundzic, Eldin, Lucchi, Naomi W., Plucinski, Mateusz M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2018
Aiheet:
Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5819161/
https://ncbi.nlm.nih.gov/pubmed/29458380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-018-2233-5
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia